|Reference : Azidothymidine as a potential modifier of radiation-reponse|
|Scientific journals : Article|
|Human health sciences : Hematology|
Human health sciences : Oncology
|Azidothymidine as a potential modifier of radiation-reponse|
|Copaceanu, M-L [ > > ]|
|COUCKE, Philippe [Centre Hospitalier Universitaire Vaudois (CHUV) > > Radiothérapie > > >]|
|Cottin, E [ > > ]|
|Mirimanoff, R-O [ > > ]|
|Taylor & Francis|
|Yes (verified by ORBi)|
|[en] radiotherapy ; Azidothymidine ; the cytotoxic effect of irradiation|
The potential effect of AZT as a thymidine analogue on radiation response in vitro was investigated. Two human cell lines (WiDr and HeLa) were used. The effect of 10 μM AZT on exponentially growing cells was studied after different exposure times (24, 48 and 72 h). The surviving fraction (clonogenic assay) or metabolic activity (MTT assay) after irradiation of AZT-exposed cells, was compared to unexposed irradiated controls. Flow cytometry was used to assess the cell-cycle effect of pre-exposure of exponentially growing cells to AZT. AZT had a radioprotective effect for all experimental time points as far as WiDr was concerned. For HeLa the effect was significant at 24 h. Cell-cycle analysis showed a significant accumulation in S-phase at 72 h for WiDr. For HeLa there was a significant accumulation in S-phase at 48 h. We conclude that under the reported experimental conditions, AZT as a thymidine analogue seems to reduce the cytotoxic effect of irradiation.
|Researchers ; Professionals|
|File(s) associated to this reference|
All documents in ORBi are protected by a user license.